[1] | Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med, 1970, 72(6): 857-868. | [2] | Nord NM, Hoeprich PD. Polymyxin B and colistin—A critical comparison. N Engl J Med, 1964, 270(20): 1030-1035. | [3] | Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis, 2009, 22(6): 535-543. | [4] | Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian GB, Dong BL, Huang XH, Yu LF, Gu DX, Ren HW, Chen XJ, Lv LC, He DD, Zhou HW, Liang ZS, Liu JH, Shen JZ. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis, 2016, 6(2): 161-168. | [5] | Rolain JM, Olaitan AO. Plasmid-mediated colistin resistance: the final blow to colistin? Int J Antimicrob Agents, 2016, 47(1): 4-5. | [6] | Raetz CR, Reynolds CM, Trent MS, Bishop RE. Lipid a modification systems in gram-negative bacteria. Annu Rev Biochem, 2007, 76: 295-329. | [7] | Fernández L, Jenssen H, Bains M, Wiegand I, Gooderham WJ, Hancock RE. The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS. Antimicrob Agents Chemother, 2012, 56(12): 6212-6222. | [8] | Gao RS, Hu YF, Li ZC, Sun J, Wang QJ, Lin JX, Ye HY, Liu F, Srinivas S, Li DF, Zhu BL, Liu YH, Tian GB, Feng YJ. Dissemination and mechanism for the MCR-1 colistin resistance. PLoS Pathog, 2016, 12(11): e1005957. | [9] | Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill, 2016, 21(9), doi: 10.2807/ 1560-7917.ES. 2016.21.9.30155. | [10] | Poirel L, Nordmann P. Emerging plasmid-encoded colistin resistance: the animal world as the culprit? J Antimicrob Chemother, 2016, 71(8): 2326-2327. | [11] | Kempf I, Jouy E, Chauvin C. Colistin use and colistin resistance in bacteria from animals. Int J Antimicrob Agents, 2016, 48(6): 598-606. | [12] | Haenni M, Poirel L, Kieffer N, Chatre P, Saras E, Métayer V, Dumoulin R, Nordmann P, Madec JY. Co-occurrence of extended spectrum β lactamase and MCR-1 encoding genes on plasmids. Lancet Infect Dis, 2016, 16(3): 281-282. | [13] | Zhang XF, Doi Y, Huang X, Li HY, Zhong LL, Zeng KJ, Zhang YF, Patil S, Tian GB. Possible transmission of mcr-1-harboring Escherichia coli between companion animals and human Emerg Infect Dis, 2016, 22(9): 1679-1681. | [14] | Yang YQ, Zhang AY, Ma SZ, Kong LH, Li YX, Liu JX, Davis MA, Guo XY, Liu BH, Lei CW, Wang HN. Co-occurrence of mcr-1 and ESBL on a single pla |
[1] |
徐纪明, 朱建树, 李梦真, 胡晗, 毛传澡. 侧翼序列获取技术研究进展[J]. 遗传, 2022, 44(4): 313-321. |
[2] |
吴丽雯, 曾洁, 薛云新, 赵西林. 细菌Cpx信号转导系统的功能及调控机制研究进展[J]. 遗传, 2021, 43(8): 747-757. |
[3] |
郑宏源, 闫琳, 杨超, 武雅蓉, 秦婧靓, 郝彤宇, 杨大进, 郭云昌, 裴晓燕, 赵彤言, 崔玉军. 溶藻弧菌群体基因组学研究[J]. 遗传, 2021, 43(4): 350-361. |
[4] |
陈湖星, 徐蕾, 李静, 郭政, 敖露. 基于结直肠癌细胞系MIC50相关基因对的基础耐药 评分模型构建[J]. 遗传, 2020, 42(6): 577-585. |
[5] |
邓雯文, 李才武, 赵思越, 李仁贵, 何永果, 吴代福, 杨盛智, 黄炎, 张和民, 邹立扣. 大熊猫源致病大肠杆菌CCHTP全基因组测序及耐药和毒力基因分析[J]. 遗传, 2019, 41(12): 1138-1147. |
[6] |
祝力骋,卢俊婉,王建,许腾,徐娟华. 肺炎克雷伯菌blaCARB-2基因的分布及结构分析[J]. 遗传, 2018, 40(7): 593-600. |
[7] |
杨盛智, 吴国艳, 龙梅, 邓雯文, 王红宁, 邹立扣. 鸡蛋生产链中沙门氏菌对抗生素及消毒剂的耐药性研究[J]. 遗传, 2016, 38(10): 948-956. |
[8] |
高薇1, 史伟1, 陈长会2, 文德年3, 田进2, 姚开虎1. 临床肺炎链球菌常见序列型青霉素耐药性的流行病学研究[J]. 遗传, 2016, 38(10): 940-947. |
[9] |
刘洋, 王邦兴, 刘志永, 韩轶, 谭耀驹, 李昕洁, 刘健雄, 谭守勇, 张天宇. 非一线抗结核药物耐药机制及耐药性诊断研究进展[J]. 遗传, 2016, 38(10): 928-939. |
[10] |
张玉娇, 李晓静, 米凯霞. 结核分枝杆菌耐氟喹诺酮类药物的分子机制研究进展[J]. 遗传, 2016, 38(10): 918-927. |
[11] |
王婷, 焦伟伟, 申阿东. 结核分枝杆菌乙胺丁醇耐药机制的研究进展[J]. 遗传, 2016, 38(10): 910-917. |
[12] |
马丽娜, 米宏霏, 薛云新, 王岱, 赵西林. ROS在细菌耐药及抗生素杀菌中的作用机制[J]. 遗传, 2016, 38(10): 902-909. |
[13] |
陈昱帆, 刘诗胤, 梁志彬, 吕明发, 周佳暖, 张炼辉. 群体感应与微生物耐药性[J]. 遗传, 2016, 38(10): 881-893. |
[14] |
张刚, 冯婕. 细菌固有耐药的研究进展[J]. 遗传, 2016, 38(10): 872-880. |
[15] |
谢龙祥, 于召箫, 郭思瑶, 李萍, AbualgasimElgailiAbdalla, 谢建平. 表观遗传和蛋白质翻译后修饰在细菌耐药中的作用[J]. 遗传, 2015, 37(8): 793-800. |
|